Psychedelics research in Canada got a major boost this week with a $5-million donation to Toronto’s University Health Network to establish the Nikean Psychedelic Psychotherapy Research Centre.
Topic: psychedelic drug therapy
Canadians need safe and legal access to psychedelic drug therapy, including psilocybin
Canadians need safe and legally controlled access to psychedelic drug therapy including psilocybin-assisted therapy which, along with providing treatment for palliative patients, would provide opportunities for research and investment, says Michael Kydd, founder and principal of Kydder Group Inc., in an op-ed.